Pediatric News
Secukinumab Shows Promise for Kids with Arthritis
Children with two subtypes of juvenile idiopathic arthritis responded well to initial treatment with secukinumab (Cosentyx), but were more likely
Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. Pediatric research, however, has led to dramatic changes in child health. Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. In 1975, a childhood diagnosis of acute lymphocytic leukemia (ALL) often meant certain death within five years, and […]
Children with two subtypes of juvenile idiopathic arthritis responded well to initial treatment with secukinumab (Cosentyx), but were more likely
Certain underlying medical conditions, as well as complex chronic illnesses exacerbated the risk for severe COVID-19 in children, researchers found
Copyright © 2024, A4M. All trademarks, registered or unregistered, are the property of their respective owners.